Filings a company makes when something has gone wrong, or is about to: a missed reporting deadline (NT 10-K/Q), a delisting from its exchange (Form 25), a deregistration that ends SEC reporting altogether (Form 15), or an insider's notice of intent to sell restricted stock (Form 144). Any one can be routine — Form 144s are filed constantly, and a late filing is sometimes just a late filing — so what is worth reading here is the pattern and the timing.
As previously disclosed, the Company undertook enhanced review of transactions in the 12 month period ended December 31, 2025 due to potential lapses in governance procedures as identified. As a re...
The Company appointed a new Chief Financial Officer during the quarter ended June 30, 2025. The related transition of financial reporting responsibilities has required additional time to complete t...
8 more red-flag filings behind a free account
See every red-flag filing BioNexus Gene Lab Corp has made, with the filing behind each one.
Sign up freeLoading...
